During the past decade, UCLA Department of Medicine conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 10 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 4 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCLA Department of Medicine" #1 sponsor was "University of California, Los Angeles" with 10 trials, followed by "Bristol-Myers Squibb" with 6 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Shire" with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Department of Medicine" #1 collaborator was "Carnegie Mellon University" with 3 trials as a collaborator, "UCLA David Geffen School of Medicine" with 3 trials as a collaborator, "UCLA Department of Medicine" with 3 trials as a collaborator, "UCLA Vatche and Tamar Manoukian Division of Digestive Diseases" with 3 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "UCLA Department of Medicine" are "COVID-19" (4 trials), "Colorectal Cancer" (3 trials), "Colorectal Neoplasms" (3 trials), "Vaccines" (3 trials) and "Acute Myeloid Leukemia" (2 trials). Many other conditions were trialed in "UCLA Department of Medicine" in a lesser frequency.

Most popular intervention types in "UCLA Department of Medicine" are "Drug" (20 trials), "Behavioral" (10 trials), "Biological" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "dasatinib" (2 trials), "ecallantide" (2 trials), "Active Colonoscopy Choice" (1 trials) and "Active Dual Choice" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA Department of Medicine" are 32 trials for "All" genders.

Currently, there are NaN active trials in "UCLA Department of Medicine". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in UCLA Department of Medicine, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UCLA Department of Medicine, 6 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".